
Dose-Escalating Study of the Safety and Pharmacokinetics of Nelfinavir in HIV-Exposed Neonates
Author(s) -
Chokechai Rongkavilit,
Rolf P. G. van Heeswijk,
Sompop Limpongsanurak,
Pimolrat Thaithumya,
Chantana Boonrod,
Elly A. M. Hassink,
Aeumporn Srigritsanapol,
Theshinee Chuenyam,
Sasiwimol Ubolyam,
Richard M. W. Hoetelmans,
Kiat Ruxrungtham,
Joep M. A. Lange,
David A. Cooper,
Praphan Phanuphak
Publication year - 2002
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00126334-200204150-00005
Subject(s) - nelfinavir , pharmacokinetics , cmin , medicine , dosing , therapeutic drug monitoring , population , pharmacology , didanosine , adverse effect , cmax , gastroenterology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , immunology , environmental health